Alejandro Cruz-Utrilla
Overview
Explore the profile of Alejandro Cruz-Utrilla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giudice F, Escribano-Subias P, Tello K, Kopec G, Ghio S, Giannakoulas G, et al.
Eur Heart J Imaging Methods Pract
. 2025 Jan;
3(1):qyae121.
PMID: 39816928
Aims: Outcome in pulmonary arterial hypertension (PAH) is determined by right ventricular (RV) function adaptation to increased afterload. Echocardiography is easily available to assist bedside evaluation of the RV. However,...
2.
Cruz-Utrilla A, Vargas-Ursua F, Fernandez-Villar A, Escribano-Subias P
Arch Bronconeumol
. 2024 Nov;
61(2):107-109.
PMID: 39516168
No abstract available.
3.
Cruz-Utrilla A, Perez-Olivares C, Luna-Lopez R, Lopez-Guarch C, Bedate P, Martinez Menaca A, et al.
Arch Bronconeumol
. 2024 Mar;
60(5):321-323.
PMID: 38461109
No abstract available.
4.
Martinez-Menaca A, Cruz-Utrilla A, Mora-Cuesta V, Luna-Lopez R, Segura-de la Cal T, Flox-Camacho A, et al.
Pulm Circ
. 2024 Feb;
14(1):e12342.
PMID: 38414916
A simplified 4-strata risk stratification approach based on three variables is widespread in pulmonary arterial hypertension (PAH) at follow-up. This study aimed to assess the impact of replacing the 6-min...
5.
Cruz-Utrilla A, Lopez-Gude M, Velazquez M, Arribas-Ynsaurriaga F, Escribano-Subias P
J Heart Lung Transplant
. 2023 Dec;
43(4):689-690.
PMID: 38141892
No abstract available.
6.
Luna-Lopez R, Segura de la Cal T, Sarnago Cebada F, Martin de Miguel I, Hinojosa W, Cruz-Utrilla A, et al.
Heart
. 2023 Oct;
110(5):346-352.
PMID: 37903556
Objective: This study assessed the long-term effects of triple therapy with prostanoids on patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD), as there is limited information on...
7.
Gallego-Zazo N, Miranda-Alcaraz L, Cruz-Utrilla A, Del Cerro Marin M, Alvarez-Fuente M, Del Mar Rodriguez Vazquez Del Rey M, et al.
Genes (Basel)
. 2023 Oct;
14(10).
PMID: 37895315
Pulmonary arterial hypertension (PAH) is an infrequent disorder characterized by high blood pressure in the pulmonary arteries. It may lead to premature death or the requirement for lung and/or heart...
8.
Del Pozo R, Cruz-Utrilla A, Escribano-Subias P
Arch Bronconeumol
. 2023 May;
59(10):617-618.
PMID: 37147267
No abstract available.
9.
Hinojosa W, Cruz-Utrilla A, Lopez-Guarch C, Velazquez-Martin M, Segura de la Cal T, Gomez-Burgueno L, et al.
Rev Esp Cardiol (Engl Ed)
. 2023 May;
76(10):774-782.
PMID: 37137424
Introduction And Objectives: The management of persistent moderate-severe tricuspid regurgitation (TR) in patients with chronic thromboembolic pulmonary hypertension after treatment with pulmonary endarterectomy (PEA) or balloon pulmonary angioplasty (BPA) is...
10.
Vera-Zambrano A, Lago-Docampo M, Gallego N, Franco-Gonzalez J, Morales-Cano D, Cruz-Utrilla A, et al.
Am J Respir Cell Mol Biol
. 2023 Mar;
69(2):147-158.
PMID: 36917789
Reduced expression and/or activity of Kv1.5 channels (encoded by ) is a common hallmark in human or experimental pulmonary arterial hypertension (PAH). Likewise, genetic variants in have been found in...